Subscribe to RSS
Download PDF
DOI: 10.1055/a-1812-5840
Clarifying the Link Between the Blood Lactate Concentration and Cardiovascular Risk
Funding This study was conducted based on funding by the investigator sites. No external funding was provided for conduction of this study.
Abstract
The blood lactate value at rest (Lacrest) is linked to cardiovascular outcomes. It is unclear whether this association holds true in younger, healthy subjects, especially as the pathophysiological connection between Lacrest and cardiometabolic disease is not well understood. The aim of this study is clarifying the link between Lacrest and cardiovascular risk, and to study explanatory factors for the variance of Lacrest concerning metabolism and physical activity in a population of healthy patient-athletes. The distribution and intra-individual variability of Lacrest was assessed based on 9051 samples. The 10-year cardiovascular risk was then approximated using the Framingham risk score in a group of 1315 samples from patient-athletes. Cross-validated linear regression was used to analyze explanatory variables for Lacrest and 10-year cardiovascular risk. Lacrest is weakly associated with the Framingham score. This association disappears when adjusting for blood lipids. Lacrest is also linked to the predominant type of exercise with endurance athletes featuring a higher Lacrest. Lacrest does not independently predict the estimated cardiovascular risk but is associated with lipid parameters. Moreover, the intra-individual variability of Lacrest is high in a relevant number of subjects, which does not point towards the feasibility to use Lacrest as an individual risk factor.
Publication History
Received: 08 February 2022
Accepted: 28 March 2022
Accepted Manuscript online:
30 March 2022
Article published online:
08 August 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Brooks GA. The science and translation of lactate shuttle theory. Cell Metab 2018; 27: 757-785
- 2 Ambe PC, Kang K, Papadakis M. et al. Can the preoperative serum lactate level predict the extent of bowel ischemia in patients presenting to the emergency department with acute mesenteric ischemia?. BioMed Res Int 2017; 2017: 8038796
- 3 Lee SM, An WS. New clinical criteria for septic shock: serum lactate level as new emerging vital sign. J Thorac Dis 2016; 8: 1388-1390
- 4 Vermeulen RP, Hoekstra M, Nijsten MW. et al. Clinical correlates of arterial lactate levels in patients with ST-segment elevation myocardial infarction at admission: a descriptive study. Crit Care 2010; 14: R164
- 5 Andersen LW, Mackenhauer J, Roberts JC. et al. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 2013; 88: 1127-1140
- 6 Sperl W. Diagnosis and therapy of mitochondriopathies. Wien Klin Wochenschr 1997; 109: 93-99
- 7 Sullivan MJ, Binkley PF, Unverferth DV. et al. Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning. J Clin Invest 1985; 76: 1632-1642
- 8 Matsushita K, Williams EK, Mongraw-Chaffin ML. et al. The association of plasma lactate with incident cardiovascular outcomes the aric study. Am J Epidemiol 2013; 178: 401-409
- 9 Crawford SO, Hoogeveen RC, Brancati FL. et al. Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol 2010; 39: 1647-1655
- 10 Juraschek SP, Shantha GPS, Chu AY. et al. Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study. PLoS One 2013; 8: e55113
- 11 Juraschek SP, Bower JK, Selvin E. et al. Plasma lactate and incident hypertension in the atherosclerosis risk in communities study. Am J Hypertens 2015; 28: 216-224
- 12 Subash Shantha GP, Wasserman B, Astor BC. et al. Association of blood lactate with carotid atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Atherosclerosis 2013; 228: 249-255
- 13 Twig G, Yaniv G, Levine H. et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med 2016; 374: 2430-2440
- 14 Newton RU, Laursen PB, Young W. Clinical exercise testing and assessment of athletes. In: Schwellnus MP, (ed.). Olympic Textbook of Medicine in Sport. Wiley-Blackwell; Oxford: 2008: 160-199
- 15 Anderson KM, Wilson PW, Odell PM. et al. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-362
- 16 Glass S, Dwyer GB. ACSM’S Metabolic Calculations Handbook. Baltimore: Lippincott Williams & Wilkins; 2007
- 17 R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, 2013. http://www.R-project.org/
- 18 Harris EK. Effects of intra and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974; 20: 1535-1542
- 19 Pinheiro J, Bates D, DebRoy S. et al. nlme: Linear and Nonlinear Mixed Effects Models. R Package Version 3,. 2012
- 20 Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976; 38: 46-51
- 21 Fong D. framinghamRiskEquation: Framingham Risk Equation calculator. 2020 https://rdrr.io/github/DavidPatShuiFong/framinghamRiskEquation/
- 22 Cohen J. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2. Ed. New York: Routledge; 1988
- 23 James G, Witten D, Hastie T. et al. An Introduction to Statistical Learning. New York: Springer; 2013
- 24 Kuhn M, Wing J, Weston S, Williams A, Keefer C, Engelhardt A, Cooper T, Mayer Z, Kenkel B, the R Core Team, Benesty M, Lescarbeau R, Ziem A, Scrucca L, Tang Y, Candan C, Hunt T (2020). “caret: Classification and Regression Training.” R package version 6.0-85, URL https://CRAN.R-project.org/package=caret
- 25 Wilson JM, Loenneke JP, Jo E. et al. The effects of endurance, strength, and power training on muscle fiber type shifting. J Strength Cond Res 2012; 26: 1724-1729
- 26 Woerle HJ, Meyer C, Dostou JM. et al. Pathways for glucose disposal after meal ingestion in humans. Am J Physiol Endocrinol Metab 2003; 284: E716-E725
- 27 Foster DW. From glycogen to ketones – and back. Diabetes 1984; 33: 1188-1199
- 28 Feneberg R, Sparber M, Veldhuis JD. et al. Synchronous fluctuations of blood insulin and lactate concentrations in humans. J Clin Endocrinol Metab 1999; 84: 220-227
- 29 Lovejoy J, Mellen B, Digirolamo M. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity. Int J Obes 1990; 14: 843-855
- 30 Nichol AD, Egi M, Pettila V. et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care 2010; 14: R25
- 31 Juraschek SP, Selvin E, Miller ER. et al. Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study. Ann Epidemiol 2013; 23: 791-796. e4
- 32 Piepoli MF, Hoes AW, Agewall S. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-2381
- 33 Damen JA, Pajouheshnia R, Heus P. et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis. BMC Med 2019; 17: 109